Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.88 +0.09 (+1.78%)
As of: Aug 21, 2026 · 2:38 PM EDT

Oramed Pharmaceuticals (ORMP) Operating Margin Growth (5y) (2021)

Oramed Pharmaceuticals (ORMP) Operating Margin Growth (5y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.64 Bn 130.78 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.89 Bn 77.90 Bn 3.93 Bn
3 Argenx Se 65.11 Bn 59.93 Bn 1.37 Bn
4 Moderna 55.83 Bn 50.69 Bn 52.00 Mn
5 BeOne Medicines 42.01 Bn 36.91 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.63 Bn 28.32 Bn 992.69 Mn
7 BioNTech SE 27.65 Bn 9.26 Bn 668.28 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
9 Royalty Pharma 27.30 Bn 26.47 Bn -
10 Oramed Pharmaceuticals 200.07 Mn 200.07 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2021 377,269.00